Inaktiver Wert

Andere Sprachen Aura Health Inc Toronto S.E.

Aktien

GIR

CA5134413031

GIR

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Pharmadrug's Securedose Announces LOI with Canadian Controlled Drug Substance Licensed Dealer for Patent Pending Pharmaceutical Grade Cocaine	23.05.
PharmaTher's Sairiyo Submits Clinical Trial Application in Australia For Phase 1 Study of Reformulated Cepharanthine	15.05.
PharmaDrug's Sairiyo Therapeutics Submits Clinical Trial Application for Phase 1 Study of Patented Reformulated Cepharanthine	15.05.
PharmaDrug Provides Forward Plan to Move Its Patent Pending Process and Formulation of Pharmaceutical Grade Biosynthetic Cocaine Through Development into Commercialization	13.05.
PharmaDrug Announces Directorate Changes	02.05.
PharmaDrug Announces Director Appointment and Resignation	02.05.
PharmaTher's Sairiyo Therapeutics Completes Regulatory Package For Phase 1 Study of Reformulated Cepharanthine in Australia	01.05.
PharmaDrug's Sairiyo Therapeutics Completes Clinical and Regulatory Package for Phase 1 Study of Patented Reformulated Cepharanthine	01.05.
Pharmadrug Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	30.04.
PharmaDrug's SecureDose Announces the Advancement of Process Development of Its Biosynthetic Formulation of Pharmaceutical Grade Cocaine	16.04.
PharmaTher Updated on its Priority Original Abbreviated New Drug Application for Ketamine	16.04.
Pharmadrug's SecureDose Announces Filing of US Provisional Patent for Manufacturing Method for Biosynthetic Pharmaceutical Grade Cocaine	13.03.
PharmaDrug's SecureDose Announces Filing of US Provisional Patent for Manufacturing Method for Biosynthetic Pharmaceutical Grade Cocaine	13.03.
PharmaDrug Inc Announces Board Changes	28.02.
PharmaDrug Appoints Current Board Member Dr. David Kideckel as Chairman	27.02.
PharmaTher Provides Update For PD-001	21.02.
PharmaDrug's Sairiyo Successfully Demonstrates Ability to Manufacture Cepharanthine (PD-001) for Human Clinical Studies	14.02.
Pharmadrug Inc. Announces Marketing and Distribution Services Agreement with Outside the Box Capital Inc	12.02.
PharmaDrug Inc. Engages Investor Relations and Marketing Service Providers	12.02.
PharmaDrug Inc. Announces Successful Closing of Non-Brokered Private Placement	08.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Aura Health Inc Toronto S.E.

Aktien

GIR

CA5134413031

GIR

Andere Sprachen

Filter